Literature DB >> 9506719

Pancreatic beta-cell responsiveness during meal tolerance test: model assessment in normal subjects and subjects with newly diagnosed noninsulin-dependent diabetes mellitus.

R Hovorka1, L Chassin, S D Luzio, R Playle, D R Owens.   

Abstract

A model-based method was developed to quantify pancreatic beta-cell responsiveness during a meal tolerance test (MTT). C peptide secretion was related in a linear fashion to glucose concentration, whereas the standard population model was used to derive transfer rate constants of the two compartmental model of C peptide kinetics. Two indexes of pancreatic beta-cell responsiveness were defined: 1) postprandial sensitivity M(I) (ability of postprandial glucose to stimulate beta-cell), and 2) basal sensitivity M0 (ability of fasting glucose to stimulate beta-cell). The method was evaluated using plasma glucose and C peptide measured over 180 min with a 10- to 30-min sampling interval during a MTT (75 g carbohydrates; 500 Cal) performed in 16 normal subjects (7 men and 9 women; age, 50 +/- 10 yr; body mass index, 29.2 +/- 3.6 kg/m2; fasting plasma glucose, 5.1 +/- 0.5 mmol/L; mean +/- SD) and 16 body mass index-matched subjects with newly diagnosed noninsulin-dependent diabetes mellitus (NIDDM; 15 men and 1 woman; age, 50 +/- 9 yr; body mass index, 29.3 +/- 3.7 kg/m2; fasting plasma glucose, 12.6 +/- 3.2 mmol/L). M(I) and M0 indexes were estimated with very good precision (coefficient of variation, < 15%). Subjects with NIDDM demonstrated lower postprandial sensitivity M(I) (17.7 +/- 11.4 vs. 90.0 +/- 43.3 x 10(-9)/min; NIDDM vs. normal, P < 0.001) and basal sensitivity M0 (5.4 +/- 2.2 vs. 10.3 +/- 4.9 x 10(-9)/min; P < 0.005). Deconvolution analysis documented that the relationship between C peptide secretion and glucose concentration is approximately linear during MTT in both normal subjects (plasma glucose range, 5-8 mmol/L) and subjects with NIDDM (12-17 mmol/L). We conclude that pancreatic responsiveness during glucose stimulation (M(I)) and under basal conditions (M0) can be obtained from this novel method during MTT in healthy and disease states.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9506719     DOI: 10.1210/jcem.83.3.4646

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  24 in total

1.  Diabetes: Models, Signals, and Control.

Authors:  Claudio Cobelli; Chiara Dalla Man; Giovanni Sparacino; Lalo Magni; Giuseppe De Nicolao; Boris P Kovatchev
Journal:  IEEE Rev Biomed Eng       Date:  2009-01-01

2.  A bio-inspired glucose controller based on pancreatic β-cell physiology.

Authors:  Pau Herrero; Pantelis Georgiou; Nick Oliver; Desmond G Johnston; Christofer Toumazou
Journal:  J Diabetes Sci Technol       Date:  2012-05-01

3.  Predictive performance for population models using stochastic differential equations applied on data from an oral glucose tolerance test.

Authors:  Jonas B Møller; Rune V Overgaard; Henrik Madsen; Torben Hansen; Oluf Pedersen; Steen H Ingwersen
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-12-16       Impact factor: 2.745

4.  Multiscale modelling of insulin secretion during an intravenous glucose tolerance test.

Authors:  Morten Gram Pedersen; Claudio Cobelli
Journal:  Interface Focus       Date:  2013-04-06       Impact factor: 3.906

5.  Abnormal lipid profile and hyperinsulinaemia after a mixed meal: additional cardiovascular risk factors in young adults born preterm.

Authors:  J Rotteveel; M M van Weissenbruch; J W R Twisk; H A Delemarre-Van de Waal
Journal:  Diabetologia       Date:  2008-05-22       Impact factor: 10.122

6.  Beta cell response to a mixed meal in nigerian patients with type 2 diabetes.

Authors:  Ekenechukwu E Young; Sonny Chinenye; Chioma N Unachukwu
Journal:  BMC Endocr Disord       Date:  2012-06-27       Impact factor: 2.763

7.  Associations between hemoglobin concentrations and the clinical characteristics of patients with type 2 diabetes.

Authors:  Jin Ook Chung; Dong Hyeok Cho; Dong Jin Chung; Min Young Chung
Journal:  Korean J Intern Med       Date:  2012-09-01       Impact factor: 2.884

8.  Parameters measuring beta-cell function are only valuable in diabetic subjects with low body mass index, high blood glucose level, or long-standing diabetes.

Authors:  Seung Won Lee; Sangheun Lee; Se Hwa Kim; Tae Ho Kim; Byung Soo Kang; Seung Hoon Yoo; Min Kyung Lee; Won Jun Koh; Won Sik Kang; Hyeong Jin Kim
Journal:  Yonsei Med J       Date:  2011-11       Impact factor: 2.759

9.  Modelling endogenous insulin concentration in type 2 diabetes during closed-loop insulin delivery.

Authors:  Yue Ruan; Hood Thabit; Malgorzata E Wilinska; Roman Hovorka
Journal:  Biomed Eng Online       Date:  2015-03-04       Impact factor: 2.819

10.  Glycemic variability correlates strongly with postprandial beta-cell dysfunction in a segment of type 2 diabetic patients using oral hypoglycemic agents.

Authors:  Klaus-Dieter Kohnert; Petra Augstein; Eckhard Zander; Peter Heinke; Karolina Peterson; Ernst-Joachim Freyse; Roman Hovorka; Eckhard Salzsieder
Journal:  Diabetes Care       Date:  2009-02-24       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.